Abstract:Cataract formation is the leading cause of blindness across the globe. The eye lens is the onset site of cataract. The eye lens is densely packed with crystallins at a high concentration. Crystallins are categorized into 3 distinct families: alpha-, beta-, and gamma-CRYs. The alpha-CRYs are known to function as a small molecule chaperone, recognizing misfolded proteins and maintaining protein homeostasis in the lens. While the beta-/gamma-CRYs serve a key structural role in lens formation through intramolecular and intermolecular interactions. Crystallins are arranged in transiently short-range order within the lens fibers. In addition, the molecular recognition and dynamic protein interactions that are medicated by crystallins serve a critical role in maintaining the transparency of the eye lens. Protein homeostasis disorder in eye lens is the main pathogenic factors causing cataract. The crystallins have a long half-life and no longer renewed after protein synthesis. Therefore, the crystallins are highly susceptible to both the extracellular and intracellular factors, such as pH, metal ions, radiation damage and post-translational modifications. These factors disrupt molecular recognition of the crystallins or alter protein-protein interactions, resulting in cataract formation. Identifying the chemical regulatory principles of molecular recognition and protein interactions of the crystallins can help elucidate the molecular mechanisms that maintain or disrupt lens transparency, along with developing innovative treatment strategies for cataract. In this review, based on recent prowess in crystallins and cataracts, we comprehensively summarized the way of molecular recognition and protein interaction in the crystallins, as well as the regulatory factors. Recent technological innovations that were enabling us to characterize interactions between the crystallins were further discussed. In addition, we investigated the application values and challenges of protein-protein interaction networks that were dominated by the crystallins in the anti-cataract drug development.

Inherited cataracts: molecular genetics, clinical features, disease mechanisms and novel therapeutic approaches

Molecular genetics of congenital cataracts

Through the Cat-Map Gateway: A Brief History of Cataract Genetics

Research Progress in Major Intrinsic Protein Genes of Congenital Cataract

Screening, Genetics, Risk Factors, and Treatment of Neonatal Cataracts

Sporadic and Familial Congenital Cataracts: Mutational Spectrum and New Diagnoses Using Next‐Generation Sequencing

The Relationship Between Major Intrinsic Protein Genes and Cataract

Gene study in congenital cataract

The Prevalence of Cataract in Children

Modeling Congenital Cataract in Vitro Using Patient-Specific Induced Pluripotent Stem Cells

Targeted Exome Sequencing of Congenital Cataracts Related Genes: Broadening the Mutation Spectrum and Genotype–Phenotype Correlations in 27 Chinese Han Families

Attention to the research about congenital cataract candidate gene

The Mutation Spectrum in Familial Versus Sporadic Congenital Cataract Based on Next-Generation Sequencing

Oxidative Stress in Genetic Cataract Formation

Current Trends in the Pharmacotherapy of Cataracts

Clinical and molecular aspects of congenital aniridia - A review of current concepts

Connexin Mutants and Cataracts

Identification of pathogenic genetic variants in patients with acquired early-onset bilateral cataracts using next-generation sequencing

Current management of infantile cataracts

New horizons in aniridia management: Clinical insights and therapeutic advances

Research Progress of Molecular Recognition and Interaction of Crystallins Linking Cataract